Clinical Trial Update: Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study) [Phase 2]

View source ↗

Summary

Phase 2 trial update on Ad26.ZEBOV booster given to HIV-positive adults previously vaccinated with Ad26.ZEBOV/MVA-BN-Filo; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ebola Virus Disease

Drugs mentioned

• Ad26.ZEBOV
• MVA-BN-Filo

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Ebola Virus Disease, Ebola | Phase 2 | Status: COMPLETED